Crossmark

Feasibility of Preoperative Dose-Painting Intensity Modulated Radiation Therapy (IMRT) for Borderline-Resectable Primary Retroperitoneal Sarcoma

Published Online: 2022-06-30

Published Print: 2022-10

Authors

Zhang, Minsi

Crago, Aimee

Yoon, Sam S.

Singer, Samuel

Alektiar, Kaled
Funding

Funding for this research was provided by:

NIH/NCI SPORE in Soft Tissue Sarcoma (P50 CA140146)

NIH/NCI Cancer Center Support Grant (P30 CA008748)
License Information

Text and Data Mining valid from 2022-06-30

Version of Record valid from 2022-06-30
More Information

Article History

Received: 10 December 2021

Accepted: 6 June 2022

First Online: 30 June 2022

Disclosure

: Dr. Aimee Crago, Advisory board—Springworks Therapeutics

Document is current